<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001972'>Macrocytic anemias</z:hpo> are commonly seen in clinical practice, and precise etiologic diagnosis is essential for proper management </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the clinical utility of reticulocyte maturation parameters in <z:hpo ids='HP_0001972'>macrocytic anemias</z:hpo> to discriminate among <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> (MA), and non-<z:e sem="disease" ids="C0002888" disease_type="Disease or Syndrome" abbrv="">megaloblastic</z:e> <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> (MA-CLD) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Using an automated reticulocyte counter, we retrospectively analyzed and compared reticulocyte maturation parameters including immature reticulocyte fraction (IRF), mean reticulocyte volume (MRV), mean sphered cell volume (MSCV) of <z:mpath ids='MPATH_458'>normal</z:mpath> control (N=34), and patients diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (N=31), MA (N=52), and MA-CLD (N=196) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:hpo ids='HP_0001972'>Macrocytic anemias</z:hpo> from MA, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and MA-CLD showed higher values of reticulocyte maturation parameters including IRF, MRV and MSCV than <z:mpath ids='MPATH_458'>normal</z:mpath> control (P&lt;0.01) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> showed higher values of reticulocyte maturation parameters including IRF, MRV and MSCV than MA-CLD (P&lt;0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>IRF and MRV were significantly lower in MA-CLD than in both MA and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (P&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>MSCV was significantly higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> than in MA (P&lt;0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: This study indicates that the measurement of reticulocyte maturation parameters may be a useful tool in the differential diagnosis of <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The presence of high values of IRF (&gt; or = 0.39), MRV (&gt; or = 129.5 fL), and MSCV (&gt; or = 102.3 fL) makes the diagnosis of MA-CLD unlikely and underlying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> should be considered </plain></SENT>
</text></document>